lupus erythematosus in pregnancy

From Aaushi
Jump to navigation Jump to search

Clinical manifestations

Laboratory

Diagnostic procedures

Complications

Management

More general terms

Additional terms

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 1.9 Medical Knowledge Self Assessment Program (MKSAP) 11, 14, 15, 16, 17. American College of Physicians, Philadelphia 1998, 2006, 2009, 2012, 2015.
  2. 2.0 2.1 Dhar JP, Essenmacher LM, Ager JW, Sokol RJ. Pregnancy outcomes before and after a diagnosis of systemic lupus erythematosus. Am J Obstet Gynecol. 2005 Oct;193(4):1444-55. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16202739
  3. Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta MA. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis. 2010 Jan;69(1):20-8 PMID: https://www.ncbi.nlm.nih.gov/pubmed/19103632
  4. Clowse ME, Jamison M, Myers E, James AH. A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol. 2008 Aug;199(2):127.e1-6 PMID: https://www.ncbi.nlm.nih.gov/pubmed/18456233
  5. Lateef A, Petri M. Management of pregnancy in systemic lupus erythematosus. Nat Rev Rheumatol. 2012 Dec;8(12):710-8. PMID: https://www.ncbi.nlm.nih.gov/pubmed/22907290
  6. Izmirly PM, Costedoat-Chalumeau N, Pisoni CN et al Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus. Circulation. 2012 Jul 3;126(1):76-82 PMID: https://www.ncbi.nlm.nih.gov/pubmed/22626746
  7. 7.0 7.1 NEJM Knowledge+ Rheumatology
  8. Clowse MEB, Eudy AM, Kiernan E et al The prevention, screening and treatment of congenital heart block from neonatal lupus: a survey of provider practices. Rheumatology (Oxford). 2018 Jul 1;57(suppl_5):v9-v17 PMID: https://www.ncbi.nlm.nih.gov/pubmed/30137589 PMCID: PMC6099126 Free PMC article PMID: https://www.ncbi.nlm.nih.gov/pubmed/19493059
  9. 9.0 9.1 NEJM Knowledge+ Nephrology/Urology